Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David V. Erbe
Observed names:
David Erbe,
David V Erbe,
David V. Erbe .,
David V. Erbe,
David V. Erbe,
Erbe, David
show all 6
Institution:
Alnylam Pharmaceuticals (United States)
Observed institutions:
Dartmouth College,
Alnylam Pharmaceuticals (United States),
Johns Hopkins University,
Inserm,
Pfizer (United States),
Genentech,
Université Paris-Saclay,
Johns Hopkins Medicine,
Bicêtre Hospital,
Wyeth,
UCL Queen Square Institute of Neurology,
University College London
show all 12
OpenAlex ID:
A5110063622
Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses
2001
·
Carin C. Stamper
, Yan Zhang
, et al.
·
Nature
·
491
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
2016
·
Abigail Liebow
, Xingsheng Li
, et al.
·
Journal of the American Society of Nephrology
·
201
Structure-Based Optimization of Protein Tyrosine Phosphatase 1B Inhibitors: From the Active Site to the Second Phosphotyrosine Binding Site
2007
·
Douglas P. Wilson
, Zhao-Kui Wan
, et al.
·
Journal of Medicinal Chemistry
·
162
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
2008
·
Dean R. Artis
, Jack J. Lin
, et al.
·
Proceedings of the National Academy of Sciences
·
151
Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists
2006
·
David V. Erbe
, Katherine Gartrell
, et al.
·
Vascular Pharmacology
·
135
Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface
2013
·
Michael M. Schmidt
, Sharon A. Townson
, et al.
·
Structure
·
120
PDF
Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis
2020
·
Simina Ticau
, Gautham V Sridharan
, et al.
·
Neurology
·
111
Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms
2004
·
David V. Erbe
, Suyue Wang
, et al.
·
Molecular Pharmacology
·
86
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1
2021
·
Yaacov Frishberg
, Georges Deschênes
, et al.
·
Clinical Journal of the American Society of Nephrology
·
84
A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia
2011
·
Lacramioara Ivanciu
, Raffaella Toso
, et al.
·
Nature Biotechnology
·
75
Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria
2020
·
Tracy L McGregor
, Karen A Hunt
, et al.
·
eLife
·
58
Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: Capturing interactions with Asp48
2006
·
Zhao-Kui Wan
, Jinbo Lee
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
58
Small Molecule Ligands Define a Binding Site on the Immune Regulatory Protein B7.1
2002
·
David V. Erbe
, Suyue Wang
, et al.
·
Journal of Biological Chemistry
·
53
PDF
Probing acid replacements of thiophene PTP1B inhibitors
2007
·
Zhao-Kui Wan
, Bruce Follows
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
45
Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity
2019
·
Kyle D. Wood
, Ross P. Holmes
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
42
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry
2021
·
Margaret M. Parker
, Scott M. Damrauer
, et al.
·
Scientific Reports
·
39
PDF
H6PDH interacts directly with 11β-HSD1: Implications for determining the directionality of glucocorticoid catalysis
2008
·
Yan-ling Zhang
, Xiaotian Zhong
, et al.
·
Archives of Biochemistry and Biophysics
·
37
Structure‐Based Optimization of Protein Tyrosine Phosphatase‐1 B Inhibitors: Capturing Interactions with Arginine 24
2008
·
Zhao‐Kui Wan
, Jinbo Lee
, et al.
·
ChemMedChem
·
18
Fcγ receptors in cancer and infectious disease
1992
·
Michael W. Fanger
, David V. Erbe
·
Immunologic Research
·
13
Mp12-14 Safety and Efficacy Study of Lumasiran, an Investigational Rna Interference (rnai) Therapeutic, in Adult and Pediatric Patients With Primary Hyperoxaluria Type 1 (ph1)
2019
·
Yaacov Frishberg
, Georges Deschenes
, et al.
·
The Journal of Urology
·
10
PPARδ Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities
2008
·
Mylène Perreault
, David V. Erbe
, et al.
·
PPAR Research
·
9
PDF
Erratum: correction: Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses
2001
·
Carin C. Stamper
, Yan Zhang
, et al.
·
Nature
·
9
PDF
Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank
2020
·
Margaret M. Parker
, Simina Ticau
, et al.
·
Amyloid
·
8
PDF
An enzyme-linked immunosorbent assay to measure insulin receptor dephosphorylation by PTP1B
2007
·
Yan-Ling Zhang
, May Tam
, et al.
·
Analytical Biochemistry
·
5
Structure—Function Aspects of Selectin—Carbohydrate Interactions
1994
·
Laurence A. Lasky
, Leonard G. Presta
, et al.
·
Springer eBooks
·
4
Show more works
View as search
Works count:
39
Citation count:
2,030
H-index:
18
I10-index:
20
Year
Topic
Type